Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan
During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk of vaccine-associated paralytic poliomyelitis and polio outbreaks due to wild and vaccine-derived polioviruses. In particular, the development of inac...
Saved in:
| Published in | Vaccine Vol. 34; no. 16; pp. 1975 - 1985 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Ltd
07.04.2016
Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0264-410X 1873-2518 1873-2518 |
| DOI | 10.1016/j.vaccine.2014.11.015 |
Cover
| Abstract | During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk of vaccine-associated paralytic poliomyelitis and polio outbreaks due to wild and vaccine-derived polioviruses. In particular, the development of inactivated poliovirus vaccines (IPVs) derived from the attenuated Sabin strains is considered to be a highly favorable option for the production of novel IPV that reduce the risk of facility-acquired transmission of poliovirus to the communities. In Japan, Sabin-derived IPVs (sIPVs) have been developed and introduced for routine immunization in November 2012. They are the first licensed sIPVs in the world. Consequently, trivalent oral poliovirus vaccine was used for polio control in Japan for more than half a century but has now been removed from the list of vaccines licensed for routine immunization. This paper reviews the development, introduction, characterization, and global status of IPV derived from attenuated Sabin strains. |
|---|---|
| AbstractList | During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk of vaccine-associated paralytic poliomyelitis and polio outbreaks due to wild and vaccine-derived polioviruses. In particular, the development of inactivated poliovirus vaccines (IPVs) derived from the attenuated Sabin strains is considered to be a highly favorable option for the production of novel IPV that reduce the risk of facility-acquired transmission of poliovirus to the communities. In Japan, Sabin-derived IPVs (sIPVs) have been developed and introduced for routine immunization in November 2012. They are the first licensed sIPVs in the world. Consequently, trivalent oral poliovirus vaccine was used for polio control in Japan for more than half a century but has now been removed from the list of vaccines licensed for routine immunization. This paper reviews the development, introduction, characterization, and global status of IPV derived from attenuated Sabin strains. Abstract During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk of vaccine-associated paralytic poliomyelitis and polio outbreaks due to wild and vaccine-derived polioviruses. In particular, the development of inactivated poliovirus vaccines (IPVs) derived from the attenuated Sabin strains is considered to be a highly favorable option for the production of novel IPV that reduce the risk of facility-acquired transmission of poliovirus to the communities. In Japan, Sabin-derived IPVs (sIPVs) have been developed and introduced for routine immunization in November 2012. They are the first licensed sIPVs in the world. Consequently, trivalent oral poliovirus vaccine was used for polio control in Japan for more than half a century but has now been removed from the list of vaccines licensed for routine immunization. This paper reviews the development, introduction, characterization, and global status of IPV derived from attenuated Sabin strains. During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk of vaccine-associated paralytic poliomyelitis and polio outbreaks due to wild and vaccine-derived polioviruses. In particular, the development of inactivated poliovirus vaccines (IPVs) derived from the attenuated Sabin strains is considered to be a highly favorable option for the production of novel IPV that reduce the risk of facility-acquired transmission of poliovirus to the communities. In Japan, Sabin-derived IPVs (sIPVs) have been developed and introduced for routine immunization in November 2012. They are the first licensed sIPVs in the world. Consequently, trivalent oral poliovirus vaccine was used for polio control in Japan for more than half a century but has now been removed from the list of vaccines licensed for routine immunization. This paper reviews the development, introduction, characterization, and global status of IPV derived from attenuated Sabin strains.During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk of vaccine-associated paralytic poliomyelitis and polio outbreaks due to wild and vaccine-derived polioviruses. In particular, the development of inactivated poliovirus vaccines (IPVs) derived from the attenuated Sabin strains is considered to be a highly favorable option for the production of novel IPV that reduce the risk of facility-acquired transmission of poliovirus to the communities. In Japan, Sabin-derived IPVs (sIPVs) have been developed and introduced for routine immunization in November 2012. They are the first licensed sIPVs in the world. Consequently, trivalent oral poliovirus vaccine was used for polio control in Japan for more than half a century but has now been removed from the list of vaccines licensed for routine immunization. This paper reviews the development, introduction, characterization, and global status of IPV derived from attenuated Sabin strains. |
| Author | Shimizu, Hiroyuki |
| Author_xml | – sequence: 1 givenname: Hiroyuki surname: Shimizu fullname: Shimizu, Hiroyuki email: hshimizu@nih.go.jp organization: WHO Global Specialized Polio Laboratory, Department of Virology II, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama-shi, Tokyo 208-0011, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25448090$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl-L1DAUxYOsuLOrH0Ep-OJLa26btCmiIrvrPxZ8WAXfQprcQsY2GZO2sN_elBkVBmR8SkJ-5yT33HtBzpx3SMhToAVQqF9ui0VpbR0WJQVWABQU-AOyAdFUeclBnJENLWuWM6Dfz8lFjFtKKa-gfUTOS86YoC3dEH2NCw5-N6KbMuVMZt0UvJn1ZL3LfJ_OKu0XNaHJdn6wfrFhjtnh8ZgZDHZJd33wY3anOuuyOAVlXUzS7LPaKfeYPOzVEPHJYb0k397ffL36mN9--fDp6t1trusGprzrFQPTI1LNas0FrUyJ2qBptRC8R12CEb2idY111ZZtZ1jFmeYArO-YaqpL8mLvuwv-54xxkqONGodBOfRzlCBYXQFtGn4aXSEBnLcJfX6Ebv0cXCpkpepkWgqWqGcHau5GNHIX7KjCvfyddAL4HtDBxxiw_4MAlWtH5VYeQpVrRyWATB1NuldHOm0ntXZnTXk4qX67V2PKfbEYZNQWnUZjA-pJGm9POrw5ctCDdVar4QfeY_ybhYylpPJunbl15IAlNaNr4a__bfAfH_gFuj7pxA |
| CitedBy_id | crossref_primary_10_1016_j_biologicals_2023_101677 crossref_primary_10_1080_21645515_2019_1572408 crossref_primary_10_3390_vaccines10020254 crossref_primary_10_1016_j_jviromet_2019_113785 crossref_primary_10_1097_INF_0000000000004478 crossref_primary_10_3390_vaccines13030253 crossref_primary_10_1080_21645515_2021_1898306 crossref_primary_10_1128_mBio_02287_18 crossref_primary_10_1097_MD_0000000000007073 crossref_primary_10_3390_vaccines10122160 crossref_primary_10_1016_j_jvacx_2022_100223 crossref_primary_10_1080_21645515_2022_2044255 crossref_primary_10_1016_j_jiac_2019_11_012 crossref_primary_10_1080_21645515_2021_1940653 crossref_primary_10_7883_yoken_JJID_2016_356 crossref_primary_10_1016_j_vaccine_2019_02_034 crossref_primary_10_1017_S0007087424001195 crossref_primary_10_1016_S1473_3099_19_30322_6 crossref_primary_10_3389_fmicb_2023_1172349 crossref_primary_10_1002_pmrj_12281 crossref_primary_10_1016_S1473_3099_19_30738_8 crossref_primary_10_7883_yoken_JJID_2022_312 crossref_primary_10_1016_j_vaccine_2020_03_027 crossref_primary_10_1080_21645515_2017_1279769 crossref_primary_10_1080_21645515_2020_1812315 crossref_primary_10_3390_vaccines9060565 crossref_primary_10_1038_s41598_022_20544_6 crossref_primary_10_1038_s41541_024_00995_w crossref_primary_10_1080_21645515_2022_2154100 crossref_primary_10_1093_cid_cix860 crossref_primary_10_3390_vaccines12020123 crossref_primary_10_1016_S2414_6447_19_30095_8 crossref_primary_10_1038_s41598_019_48534_1 crossref_primary_10_1016_j_vaccine_2021_01_027 crossref_primary_10_2490_jjrmc_57_736 crossref_primary_10_1016_j_biologicals_2018_02_001 crossref_primary_10_1371_journal_ppat_1006117 crossref_primary_10_1038_s41541_019_0108_6 crossref_primary_10_3390_pathogens13030224 crossref_primary_10_32604_cmes_2023_023231 crossref_primary_10_1128_JVI_00976_18 |
| Cites_doi | 10.1111/j.1348-0421.1987.tb03093.x 10.1016/j.vaccine.2011.05.079 10.1001/jama.292.14.1696 10.1016/S0140-6736(12)60232-3 10.1016/j.tmaid.2010.05.004 10.1126/science.1255006 10.7883/yoken.JJID.2002.101 10.1007/BF00443199 10.7883/yoken.52.146 10.1371/journal.ppat.1002599 10.1099/0022-1317-83-5-1107 10.1111/j.1442-200X.2010.03132.x 10.7883/yoken.63.216 10.1016/j.vaccine.2014.07.029 10.1099/vir.0.19088-0 10.1056/NEJMoa1304923 10.1371/journal.pone.0083374 10.1111/j.1348-0421.1981.tb00059.x 10.1086/424524 10.1586/erv.11.51 10.1016/j.vaccine.2014.07.065 10.2807/1560-7917.ES2014.19.7.20708 10.1016/S0140-6736(05)66386-6 10.1016/j.vaccine.2012.04.026 10.1056/NEJMoa1303224 10.1093/infdis/jir723 10.1086/506949 10.1016/j.vaccine.2013.09.021 10.1099/0022-1317-74-4-685 10.1093/aje/kwq320 10.1016/j.vaccine.2008.07.026 10.1016/S0140-6736(13)60286-X 10.1111/j.1348-0421.1981.tb00095.x 10.1016/S0887-8994(00)00167-3 10.1128/AEM.66.11.5087-5091.2000 10.1016/j.vaccine.2013.12.025 10.1016/S0264-410X(98)00409-5 10.1016/j.biologicals.2012.12.004 10.1097/00006454-200101000-00013 10.7883/yoken1952.48.61 10.1006/biol.1997.0100 10.7883/yoken1952.19.277 10.1006/biol.1993.1070 10.1111/j.1348-0421.1983.tb02939.x 10.1093/infdis/jiu164 10.1016/S0264-410X(00)00350-9 10.1016/j.vaccine.2014.02.093 10.1016/j.vaccine.2012.12.076 10.1016/S1473-3099(13)70330-X 10.1016/j.biologicals.2006.02.010 10.1016/j.jviromet.2013.10.004 10.1128/IAI.37.1.46-53.1982 10.1007/s10156-010-0065-5 10.1038/502601a 10.1016/j.biologicals.2006.02.011 10.1016/j.biologicals.2006.03.003 10.2222/jsv.36.125 10.7883/yoken.JJID.2008.100 10.1016/S0140-6736(12)61764-4 10.1146/annurev.micro.58.030603.123625 10.1016/j.vaccine.2011.02.085 10.1016/S0140-6736(00)02868-3 10.1016/S0140-6736(13)62331-4 10.1093/infdis/jit155 10.1093/aje/kwt203 10.1080/00365540110027204 10.1097/00006454-198811000-00003 10.1016/j.vaccine.2014.07.109 10.1016/j.vaccine.2007.07.060 10.4155/ppa.12.70 10.1016/j.vaccine.2014.04.023 |
| ContentType | Journal Article |
| Copyright | 2014 Elsevier Ltd Elsevier Ltd Copyright © 2014 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Apr 7, 2016 |
| Copyright_xml | – notice: 2014 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2014 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Apr 7, 2016 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 7S9 L.6 |
| DOI | 10.1016/j.vaccine.2014.11.015 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection ProQuest Consumer Health Database (NC LIVE) Health & Medical Collection (Alumni Edition) Healthcare Administration Database PML(ProQuest Medical Library) Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Biological Science Database (NC LIVE) Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE AGRICOLA Research Library Prep MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-2518 |
| EndPage | 1985 |
| ExternalDocumentID | 4001078141 25448090 10_1016_j_vaccine_2014_11_015 S0264410X14015400 1_s2_0_S0264410X14015400 |
| Genre | Historical Article Review Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGUBO AGYEJ AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 ROL RPZ SAB SCC SDF SDG SDP SES SNL SPCBC SSH SSI SSZ T5K UKHRP UV1 WH7 WOW Z5R ~G- .GJ 29Q 3V. AACTN AAQXK ABWVN ABXDB ACRPL ADMUD ADNMO ADVLN AFCTW AFJKZ AFKWA AGHFR AHHHB AJOXV ALIPV AMFUW ASPBG AVWKF AZFZN FEDTE FGOYB G-2 HEJ HLV HMG HMK HMO HVGLF HX~ HZ~ R2- RIG SAE SEW SIN SVS WUQ XPP ZGI ZXP AAIAV ABLVK ABYKQ AESVU AJBFU EFLBG LCYCR QYZTP AAYXX ACMHX ADSLC AGQPQ AGRNS AGWPP AIGII CITATION CGR CUY CVF ECM EIF NPM 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI Q9U 7X8 ACLOT ~HD 7S9 L.6 |
| ID | FETCH-LOGICAL-c671t-bfa41dfee0c46c5803d2ecded9c885fec21d8fa066e63929bd4354c5114fb4a73 |
| IEDL.DBID | .~1 |
| ISSN | 0264-410X 1873-2518 |
| IngestDate | Sun Sep 28 11:32:35 EDT 2025 Sat Sep 27 23:05:25 EDT 2025 Wed Aug 13 07:24:58 EDT 2025 Thu Apr 03 07:12:15 EDT 2025 Sun Jul 06 05:05:32 EDT 2025 Thu Apr 24 23:04:47 EDT 2025 Fri Feb 23 02:21:12 EST 2024 Tue Feb 25 20:08:39 EST 2025 Tue Aug 26 16:33:06 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 16 |
| Keywords | Sabin strain Global polio eradication Inactivated poliovirus vaccine Oral poliovirus vaccine Poliovirus vaccine Poliovirus Vaccine-associated paralytic poliomyelitis Vaccine-derived poliovirus |
| Language | English |
| License | Copyright © 2014 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c671t-bfa41dfee0c46c5803d2ecded9c885fec21d8fa066e63929bd4354c5114fb4a73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| PMID | 25448090 |
| PQID | 1776184284 |
| PQPubID | 105530 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_1846310775 proquest_miscellaneous_1775381559 proquest_journals_1776184284 pubmed_primary_25448090 crossref_primary_10_1016_j_vaccine_2014_11_015 crossref_citationtrail_10_1016_j_vaccine_2014_11_015 elsevier_sciencedirect_doi_10_1016_j_vaccine_2014_11_015 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X14015400 elsevier_clinicalkey_doi_10_1016_j_vaccine_2014_11_015 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-04-07 |
| PublicationDateYYYYMMDD | 2016-04-07 |
| PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-07 day: 07 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands – name: Kidlington |
| PublicationTitle | Vaccine |
| PublicationTitleAlternate | Vaccine |
| PublicationYear | 2016 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | Vidor, Plotokin (bib0310) 2013 Hennessey, Schluter, Wang, Boualam, Jee, Mendoza-Aldana (bib0135) 2014; 32 Iwai, Matsuura, Hasegawa, Obara, Horimoto, Nagai (bib0125) 2005; 28 Hosoda, Inoue, Miyazawa, Kusumi, Shibuya (bib0350) 2012; 379 Li, Liu, Mo, Wang, Xia, Liang (bib0535) 2014; 370 National Institute of Infectious Diseases (bib0315) 2010 Inaba, Hori, Ito, Kuze, Ishiko, Asmar (bib0150) 2001; 33 Alexander, Seward, Santibanez, Pallansch, Kew, Prevots (bib0325) 2004; 292 Saitoh, Okabe (bib0345) 2012; 30 Ministry of Health (bib0355) 2014 Ministry of Health (bib0335) 2012 Dowdle, Wolff (bib0025) 2006; 34 Simizu, Abe, Yamamoto, Tano, Ota, Miyazawa (bib0190) 2006; 34 Takeda Pharmaceutical Company Limited (bib0390) 2011 Miyoshi, Yoshizumi, Jinushi, Ishida, Okui, Okano (bib0160) 2010; 63 Bakker, Thomassen, Van’t Oever, Westdijk, van Oijen, Sundermann (bib0495) 2011; 29 Yoshida, Horie, Matsuura, Kitamura, Hashizume, Miyamura (bib0420) 2002; 83 Yamazaki, Abe (bib0185) 2011; 26 Pallansch, Oberste (bib0520) 2013; 381 . Liao, Li, Li, Sun, Li, Chu (bib0415) 2012; 205 Shirato, Someya, Ochiai, Horiuchi, Takahashi, Takeda (bib0280) 2014; 32 Abe, Tano, Ohta, Horie, Miyazawa, Wakabayashi (bib0200) 1999; 27 Pharmaceuticals and Medical Devices Agency (bib0300) 2012 Paul (bib0045) 1947; 45 Adams, Boualam, Diorditsa, Gregory, Jee, Mendoza-Aldana (bib0130) 2014 World Health Organization (bib0505) 2013 Hao, Toyokawa, Kobayashi (bib0175) 2008; 61 World Health Organization (bib0210) 2004 Verdijk, Rots, van Oijen, Oberste, Boog, Okayasu (bib0410) 2013; 31 Takayama, Sakiyama, Shimizu, Umemoto (bib0370) 2014; 143 Matsuura, Ishikura, Yoshida, Nakayama, Hasegawa, Ando (bib0430) 2000; 66 Verdijk, Rots, Bakker (bib0490) 2011; 10 Martin, Crossland, Wood, Minor (bib0230) 2003; 84 Nakatani, Sano, Iuchi (bib0340) 2002; 55 Sato, Shiosaki, Goto, Sonoda, Kino (bib0285) 2013; 41 World Health Organization (bib0005) 2014; 32 Resik, Tejeda, Fonseca, Alemani, Diaz, Martinez (bib0480) 2014; 32 Kono (bib0040) 1960; 3 Abo, Chiba, Yamanaka, Nakao, Hara, Tagaya (bib0100) 1979; 132 Ministry of Health (bib0375) 2014 Verdijk, Rots, van Oijen, Weldon, Oberste, Okayasu (bib0405) 2014; 32 Sawyer, Wood, Ferguson, Crainic, Beuvery, McInnis (bib0240) 1997; 25 Asahina, Matsunami, Sueda, Shiraishi, Saitoh (bib0170) 2010; 52 Tagaya, Nakao, Hara, Yamadera (bib0065) 1973; 48 Shimizu, Nakashima (bib0515) 2014; 14 Vaccine Administration Subcommittee (bib0055) 1966; 19 Westdijk, Koedam, Barro, Steil, Collin, Vedvick (bib0255) 2013; 31 Butler (bib0440) 2013; 502 World Health Organization (bib0020) 2009 Tano, Shimizu, Martin, Nishimura, Simizu, Miyamura (bib0225) 2007; 25 Okada, Miyazaki, Kino, Ozaki, Hirose, Ueda (bib0290) 2013; 208 Hara, Hagiwara, Yoneyama, Saito, Shimojo (bib0085) 1983; 27 Fujioka, Iijima (bib0360) 2013; 117 Nathanson, Kew (bib0035) 2010; 172 Kreeftenberg, van der Velden, Kersten, van der Heuvel, de Bruijn (bib0500) 2006; 34 Horie, Miyazawa, Ota, Wakabayashi, Yoshida, Doi (bib0215) 2001; 19 Hagiwara, Yoneyama, Yoshii, Yoshida, Shimizu, Wada (bib0510) 1999; 52 Ferguson, Wood, Minor (bib0250) 1993; 74 Murph, Grose, McAndrew, Mickiewicz, Mento, Cano (bib0400) 1988; 7 Maurice (bib0140) 2000; 78 Westdijk, Brugmans, Martin, van’t Oever, Bakker, Levels (bib0265) 2011; 29 Yoneyama, Hagiwara, Hara, Shimojo (bib0105) 1982; 37 World Health Organization (bib0010) 2013 Ministry of Health (bib0220) 2011 Huang, Greening, Baker, Grimwood, Hewitt, Hulston (bib0455) 2005; 366 Kersten, Hazendonk, Beuvery (bib0235) 1999; 17 Sutter, Kew, Cochi, Aylward (bib0060) 2013 Iwai-Itamochi, Yoshida, Obara-Nagoya, Horimoto, Kurata, Takizawa (bib0450) 2014; 195 Abe, Yamaki, Doi (bib0205) 1986; 36 Higashigawa, Maegawa, Honma, Yoshino, Onozato, Nashida (bib0165) 2010; 16 Ministry of Health (bib0180) 2011 Takatsu, Tagaya, Hirayama (bib0050) 1973; 49 Thomassen, van’tOever, van Oijen, Wijffels, van der Pol, Bakker (bib0260) 2013; 8 Nakano, Hatch, Thieme, Nottay (bib0070) 1978; 24 Ozawa, Noma, Yoshida, Sekine, Hashimoto (bib0145) 2000; 23 Hamidi, Bakker (bib0485) 2012; 1 Jafari, Deshpande, Sutter, Bahl, Verma, Ahmad (bib0460) 2014; 345 Plotkin (bib0525) 2001; 20 Zhu, Liang, Li, Ge, Meng, Mao (bib0540) 2013; 381 Yoneyama, Hagiwara, Hara (bib0090) 1981; 25 Pharmaceuticals and Medical Devices Agency (bib0305) 2012 Tulchinsky, Ramlawi, Abdeen, Grotto, Flahault (bib0435) 2013; 382 Bonnet, Dutta (bib0320) 2008; 26 Ogawa (bib0295) 2013; 28 Hara, Saito, Komatsu, Kodama, Abo, Chiba (bib0110) 1981; 25 Zhu, Xu, Xia, Liang, Liu, Zhang (bib0530) 2014; 370 Hara, Arita, Yamazaki, Hagiwara, Saito (bib0080) 1987; 31 Dragunsky, Ivanov, Wells, Ivshina, Rezapkin, Abe (bib0275) 2004; 190 National Committee for the Certification of Poliomyelitis Eradication of Japan (bib0120) 2012 Manor, Shulman, Kaliner, Hindiyeh, Ram, Sofer (bib0445) 2014; 19 Yoshida, Horie, Matsuura, Miyamura (bib0425) 2000; 356 Mangal, Aylward, Grassly (bib0465) 2013; 178 Doi, Abe, Yamamoto, Horie, Ohyama, Satoh (bib0195) 2001; 105 Hirai (bib0030) 1910; 125 Takayama, Shimizu, Umemoto (bib0365) 2012; 141 National Committee for the Certification of Poliomyelitis Eradication of Japan (bib0380) 2013 Sanofi Pasteur. [in Japanese] IMOVAX POLIO subcutaneous. Kew, Sutter, de Gourville, Dowdle, Pallansch (bib0115) 2005; 59 Nakano (bib0155) 2011; 9 Global Polio Eradication Initiative (bib0015) 2012 Ministry of Health (bib0395) 2013 Kitahara, Hara, Nakao, Yamazaki, Soda, Sasaki (bib0075) 1963; 16 Pharmaceuticals and Medical Devices Agency (bib0385) 2014 Dragunsky, Ivanov, Abe, Potapova, Enterline, Hashizume (bib0270) 2006; 194 Yoneyama, Fujiwara, Yokota, Takemika, Hagiwara (bib0095) 1995; 48 Hird, Grassly (bib0470) 2012; 8 Sawyer, McInnis, Albrecht (bib0245) 1993; 21 Sun, Ma, Xu, Yang, Shi, Che (bib0475) 2014; 32 Hosoda (10.1016/j.vaccine.2014.11.015_bib0350) 2012; 379 Dragunsky (10.1016/j.vaccine.2014.11.015_bib0270) 2006; 194 Pharmaceuticals and Medical Devices Agency (10.1016/j.vaccine.2014.11.015_bib0300) 2012 Manor (10.1016/j.vaccine.2014.11.015_bib0445) 2014; 19 World Health Organization (10.1016/j.vaccine.2014.11.015_bib0005) 2014; 32 Westdijk (10.1016/j.vaccine.2014.11.015_bib0265) 2011; 29 Hao (10.1016/j.vaccine.2014.11.015_bib0175) 2008; 61 Zhu (10.1016/j.vaccine.2014.11.015_bib0540) 2013; 381 Kersten (10.1016/j.vaccine.2014.11.015_bib0235) 1999; 17 Sato (10.1016/j.vaccine.2014.11.015_bib0285) 2013; 41 Thomassen (10.1016/j.vaccine.2014.11.015_bib0260) 2013; 8 Yoneyama (10.1016/j.vaccine.2014.11.015_bib0090) 1981; 25 Hagiwara (10.1016/j.vaccine.2014.11.015_bib0510) 1999; 52 National Institute of Infectious Diseases (10.1016/j.vaccine.2014.11.015_bib0315) 2010 Saitoh (10.1016/j.vaccine.2014.11.015_bib0345) 2012; 30 Paul (10.1016/j.vaccine.2014.11.015_bib0045) 1947; 45 Iwai (10.1016/j.vaccine.2014.11.015_bib0125) 2005; 28 Nakano (10.1016/j.vaccine.2014.11.015_bib0070) 1978; 24 Global Polio Eradication Initiative (10.1016/j.vaccine.2014.11.015_bib0015) 2012 Kono (10.1016/j.vaccine.2014.11.015_bib0040) 1960; 3 Tagaya (10.1016/j.vaccine.2014.11.015_bib0065) 1973; 48 Kitahara (10.1016/j.vaccine.2014.11.015_bib0075) 1963; 16 Plotkin (10.1016/j.vaccine.2014.11.015_bib0525) 2001; 20 World Health Organization (10.1016/j.vaccine.2014.11.015_bib0020) 2009 Sawyer (10.1016/j.vaccine.2014.11.015_bib0245) 1993; 21 Horie (10.1016/j.vaccine.2014.11.015_bib0215) 2001; 19 Yoneyama (10.1016/j.vaccine.2014.11.015_bib0105) 1982; 37 Ministry of Health (10.1016/j.vaccine.2014.11.015_bib0335) 2012 Li (10.1016/j.vaccine.2014.11.015_bib0535) 2014; 370 Ministry of Health (10.1016/j.vaccine.2014.11.015_bib0355) 2014 Ministry of Health (10.1016/j.vaccine.2014.11.015_bib0375) 2014 Ministry of Health (10.1016/j.vaccine.2014.11.015_bib0395) 2013 Pharmaceuticals and Medical Devices Agency (10.1016/j.vaccine.2014.11.015_bib0305) 2012 Sutter (10.1016/j.vaccine.2014.11.015_bib0060) 2013 Maurice (10.1016/j.vaccine.2014.11.015_bib0140) 2000; 78 Takeda Pharmaceutical Company Limited (10.1016/j.vaccine.2014.11.015_bib0390) 2011 Hirai (10.1016/j.vaccine.2014.11.015_bib0030) 1910; 125 Takayama (10.1016/j.vaccine.2014.11.015_bib0365) 2012; 141 Yoshida (10.1016/j.vaccine.2014.11.015_bib0425) 2000; 356 Ministry of Health (10.1016/j.vaccine.2014.11.015_bib0220) 2011 Liao (10.1016/j.vaccine.2014.11.015_bib0415) 2012; 205 Takatsu (10.1016/j.vaccine.2014.11.015_bib0050) 1973; 49 Takayama (10.1016/j.vaccine.2014.11.015_bib0370) 2014; 143 Nathanson (10.1016/j.vaccine.2014.11.015_bib0035) 2010; 172 Tulchinsky (10.1016/j.vaccine.2014.11.015_bib0435) 2013; 382 Mangal (10.1016/j.vaccine.2014.11.015_bib0465) 2013; 178 World Health Organization (10.1016/j.vaccine.2014.11.015_bib0010) 2013 Ozawa (10.1016/j.vaccine.2014.11.015_bib0145) 2000; 23 Abe (10.1016/j.vaccine.2014.11.015_bib0200) 1999; 27 Vaccine Administration Subcommittee (10.1016/j.vaccine.2014.11.015_bib0055) 1966; 19 Asahina (10.1016/j.vaccine.2014.11.015_bib0170) 2010; 52 Kew (10.1016/j.vaccine.2014.11.015_bib0115) 2005; 59 Pallansch (10.1016/j.vaccine.2014.11.015_bib0520) 2013; 381 Vidor (10.1016/j.vaccine.2014.11.015_bib0310) 2013 Fujioka (10.1016/j.vaccine.2014.11.015_bib0360) 2013; 117 Bakker (10.1016/j.vaccine.2014.11.015_bib0495) 2011; 29 Huang (10.1016/j.vaccine.2014.11.015_bib0455) 2005; 366 Verdijk (10.1016/j.vaccine.2014.11.015_bib0490) 2011; 10 Verdijk (10.1016/j.vaccine.2014.11.015_bib0405) 2014; 32 Inaba (10.1016/j.vaccine.2014.11.015_bib0150) 2001; 33 Resik (10.1016/j.vaccine.2014.11.015_bib0480) 2014; 32 Ministry of Health (10.1016/j.vaccine.2014.11.015_bib0180) 2011 Shimizu (10.1016/j.vaccine.2014.11.015_bib0515) 2014; 14 Dowdle (10.1016/j.vaccine.2014.11.015_bib0025) 2006; 34 Ferguson (10.1016/j.vaccine.2014.11.015_bib0250) 1993; 74 Kreeftenberg (10.1016/j.vaccine.2014.11.015_bib0500) 2006; 34 Yamazaki (10.1016/j.vaccine.2014.11.015_bib0185) 2011; 26 Okada (10.1016/j.vaccine.2014.11.015_bib0290) 2013; 208 Verdijk (10.1016/j.vaccine.2014.11.015_bib0410) 2013; 31 Abe (10.1016/j.vaccine.2014.11.015_bib0205) 1986; 36 Dragunsky (10.1016/j.vaccine.2014.11.015_bib0275) 2004; 190 Matsuura (10.1016/j.vaccine.2014.11.015_bib0430) 2000; 66 Abo (10.1016/j.vaccine.2014.11.015_bib0100) 1979; 132 Westdijk (10.1016/j.vaccine.2014.11.015_bib0255) 2013; 31 Alexander (10.1016/j.vaccine.2014.11.015_bib0325) 2004; 292 Pharmaceuticals and Medical Devices Agency (10.1016/j.vaccine.2014.11.015_bib0385) 2014 Yoshida (10.1016/j.vaccine.2014.11.015_bib0420) 2002; 83 Sawyer (10.1016/j.vaccine.2014.11.015_bib0240) 1997; 25 Nakatani (10.1016/j.vaccine.2014.11.015_bib0340) 2002; 55 Zhu (10.1016/j.vaccine.2014.11.015_bib0530) 2014; 370 10.1016/j.vaccine.2014.11.015_bib0330 Tano (10.1016/j.vaccine.2014.11.015_bib0225) 2007; 25 Martin (10.1016/j.vaccine.2014.11.015_bib0230) 2003; 84 Butler (10.1016/j.vaccine.2014.11.015_bib0440) 2013; 502 Simizu (10.1016/j.vaccine.2014.11.015_bib0190) 2006; 34 Murph (10.1016/j.vaccine.2014.11.015_bib0400) 1988; 7 Higashigawa (10.1016/j.vaccine.2014.11.015_bib0165) 2010; 16 Iwai-Itamochi (10.1016/j.vaccine.2014.11.015_bib0450) 2014; 195 Doi (10.1016/j.vaccine.2014.11.015_bib0195) 2001; 105 Hara (10.1016/j.vaccine.2014.11.015_bib0110) 1981; 25 Hennessey (10.1016/j.vaccine.2014.11.015_bib0135) 2014; 32 Ogawa (10.1016/j.vaccine.2014.11.015_bib0295) 2013; 28 Nakano (10.1016/j.vaccine.2014.11.015_bib0155) 2011; 9 Shirato (10.1016/j.vaccine.2014.11.015_bib0280) 2014; 32 Miyoshi (10.1016/j.vaccine.2014.11.015_bib0160) 2010; 63 Adams (10.1016/j.vaccine.2014.11.015_bib0130) 2014 Jafari (10.1016/j.vaccine.2014.11.015_bib0460) 2014; 345 World Health Organization (10.1016/j.vaccine.2014.11.015_bib0505) 2013 Hird (10.1016/j.vaccine.2014.11.015_bib0470) 2012; 8 Hamidi (10.1016/j.vaccine.2014.11.015_bib0485) 2012; 1 Sun (10.1016/j.vaccine.2014.11.015_bib0475) 2014; 32 Hara (10.1016/j.vaccine.2014.11.015_bib0085) 1983; 27 Yoneyama (10.1016/j.vaccine.2014.11.015_bib0095) 1995; 48 National Committee for the Certification of Poliomyelitis Eradication of Japan (10.1016/j.vaccine.2014.11.015_bib0380) 2013 Hara (10.1016/j.vaccine.2014.11.015_bib0080) 1987; 31 Bonnet (10.1016/j.vaccine.2014.11.015_bib0320) 2008; 26 National Committee for the Certification of Poliomyelitis Eradication of Japan (10.1016/j.vaccine.2014.11.015_bib0120) 2012 World Health Organization (10.1016/j.vaccine.2014.11.015_bib0210) 2004 |
| References_xml | – volume: 48 start-page: 61 year: 1995 end-page: 70 ident: bib0095 article-title: Characterization of a wild poliovirus type 3 isolated Japan in 1993 publication-title: Jpn J Med Sci Biol – year: 2004 ident: bib0210 article-title: WHO global action plan for laboratory containment of wild polioviruses – volume: 125 start-page: 759 year: 1910 end-page: 769 ident: bib0030 article-title: On the Hein Mwdin's disease publication-title: Jikazasshi – volume: 141 start-page: 1052 year: 2012 end-page: 1058 ident: bib0365 article-title: A survey of the number of immunization with inctibvated poliovius vaccine; The survey results in 2011 publication-title: J Jpn Med Assoc – volume: 366 start-page: 394 year: 2005 end-page: 396 ident: bib0455 article-title: Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand publication-title: Lancet – volume: 34 start-page: 127 year: 2006 end-page: 132 ident: bib0025 article-title: Post-eradication poliovirus facility-associated community risks publication-title: Biologicals – volume: 26 start-page: 4978 year: 2008 end-page: 4983 ident: bib0320 article-title: World wide experience with inactivated poliovirus vaccine publication-title: Vaccine – year: 2009 ident: bib0020 article-title: WHO global action plan to minimize poliovirus facility-associated risk after eradication of wild polioviruses and cessation of routine OPV use – volume: 26 start-page: 45 year: 2011 end-page: 51 ident: bib0185 article-title: Developmemnt of Sabin strain-derived inactivated poliovirus vaccine in Japan publication-title: BIO Clinica – start-page: 573 year: 2013 end-page: 597 ident: bib0310 article-title: Poliovirus vaccine-inactivated publication-title: Vaccines – volume: 143 start-page: 609 year: 2014 end-page: 614 ident: bib0370 article-title: Cummulative vaccination covrrage of oral poliovirus vaccine and inactivated poliovirus vaccine obtained by the nationwide survey in 2013 publication-title: J Jpn Med Assoc – volume: 36 start-page: 125 year: 1986 end-page: 137 ident: bib0205 article-title: Preparation of inactivated poliomyelitis vaccine with attenuated Sabin strains publication-title: Uirusu – volume: 345 start-page: 922 year: 2014 end-page: 925 ident: bib0460 article-title: Polio eradication. Efficacy of inactivated poliovirus vaccine in India publication-title: Science – volume: 16 start-page: 135 year: 1963 end-page: 145 ident: bib0075 article-title: Studies on the antigenic serodifferentiation of poliovirus strains publication-title: Jpn J Med Sci Biol – volume: 117 start-page: 766 year: 2013 end-page: 772 ident: bib0360 article-title: Imported inactibated polio vaccine use in Kobe city Nihon Shonika Gakkai Zasshi publication-title: J Jpn Pediatr Soc – volume: 370 start-page: 818 year: 2014 end-page: 828 ident: bib0530 article-title: Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China publication-title: N Engl J Med – year: 2014 ident: bib0130 article-title: Maintaining polio-free certification in the World Health Organization Western Pacific Region for over a decade publication-title: J Infect Dis – volume: 132 start-page: 11 year: 1979 end-page: 16 ident: bib0100 article-title: Paralytic poliomyelitis in a child with agammaglobulinemia publication-title: Eur J Pediatr – volume: 30 start-page: 4752 year: 2012 end-page: 4756 ident: bib0345 article-title: Current issues with the immunization program in Japan: can we fill the “vaccine gap”? publication-title: Vaccine – volume: 63 start-page: 216 year: 2010 end-page: 217 ident: bib0160 article-title: A case of paralytic poliomyelitis associated with poliovirus vaccine strains in hokkaido, Japan publication-title: Jpn J Infect Dis – volume: 32 start-page: 4117 year: 2014 end-page: 4118 ident: bib0005 article-title: Polio vaccines: WHO position paper, January 2014—recommendations publication-title: Vaccine – volume: 28 start-page: 72 year: 2013 end-page: 79 ident: bib0295 article-title: Efficacy and safety of absorbed acellular pertussis–diphtheria–tetanus–Sabin strains derivd inactivated poliovirus combination vaccine publication-title: BIO Clin – volume: 25 start-page: 575 year: 1981 end-page: 583 ident: bib0090 article-title: Structural proteins of poliovirus type 2 isolates publication-title: Microbiol Immunol – volume: 52 start-page: 146 year: 1999 end-page: 149 ident: bib0510 article-title: Genetic analysis of wild polioviruses towards the eradication of poliomyelitis from the Western Pacific Region publication-title: Jpn J Infect Dis – volume: 84 start-page: 1781 year: 2003 end-page: 1788 ident: bib0230 article-title: Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains publication-title: J Gen Virol – volume: 31 start-page: 5531 year: 2013 end-page: 5536 ident: bib0410 article-title: Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults publication-title: Vaccine – volume: 105 start-page: 163 year: 2001 end-page: 169 ident: bib0195 article-title: Progress with inactivated poliovirus vaccines derived from the Sabin strains publication-title: DevBiol – volume: 52 start-page: 838 year: 2010 end-page: 841 ident: bib0170 article-title: Vaccine-associated paralytic poliomyelitis in a non-immunocompromised infant publication-title: Pediatr Int – year: 2014 ident: bib0355 article-title: Labour and Welfare publication-title: On the immunization rates in JFY 2012 – volume: 25 start-page: 299 year: 1997 end-page: 306 ident: bib0240 article-title: Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site publication-title: Biologicals – volume: 178 start-page: 1579 year: 2013 end-page: 1587 ident: bib0465 article-title: The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting publication-title: Am J Epidemiol – volume: 78 start-page: 1479 year: 2000 ident: bib0140 article-title: A second WHO region declared polio-free publication-title: Bull World Health Organ – volume: 55 start-page: 101 year: 2002 end-page: 111 ident: bib0340 article-title: Development of vaccination policy in Japan: current issues and policy directions publication-title: Jpn J Infect Dis – volume: 31 start-page: 1298 year: 2013 end-page: 1304 ident: bib0255 article-title: Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains publication-title: Vaccine – volume: 25 start-page: 905 year: 1981 end-page: 913 ident: bib0110 article-title: Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration publication-title: Microbiol Immunol – volume: 19 start-page: 1456 year: 2001 end-page: 1459 ident: bib0215 article-title: Analysis of the accumulation of mutants in Sabin attenuated polio vaccine viruses passaged in Vero cells publication-title: Vaccine – volume: 34 start-page: 155 year: 2006 end-page: 158 ident: bib0500 article-title: Technology transfer of Sabin-IPV to new developing country markets publication-title: Biologicals – volume: 32 start-page: 4259 year: 2014 end-page: 4266 ident: bib0135 article-title: Are we there yet? Assessing achievement of vaccine-preventable disease goals in WHO's Western Pacific Region publication-title: Vaccine – volume: 37 start-page: 46 year: 1982 end-page: 53 ident: bib0105 article-title: Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients publication-title: Infect Immun – volume: 28 start-page: 80 year: 2005 end-page: 84 ident: bib0125 article-title: Isolation of vaccine-derived strain in epodemiological surveillnace of poliovirus publication-title: Annual report of Toyama Institute of Health – volume: 195 start-page: 148 year: 2014 end-page: 155 ident: bib0450 article-title: Development of real-time PCR to detect oral vaccine-like poliovirus and its application to environmental surveillance publication-title: J Virol Methods – volume: 172 start-page: 1213 year: 2010 end-page: 1229 ident: bib0035 article-title: From emergence to eradication: the epidemiology of poliomyelitis deconstructed publication-title: Am J Epidemiol – volume: 3 start-page: 1 year: 1960 end-page: 41 ident: bib0040 article-title: Poliomyelitis in Japan publication-title: Annu Rep Inst Virus Res, Kyoto Univ – volume: 23 start-page: 177 year: 2000 end-page: 179 ident: bib0145 article-title: Acute disseminated encephalomyelitis associated with poliomyelitis vaccine publication-title: Pediatr Neurol – volume: 17 start-page: 2059 year: 1999 end-page: 2066 ident: bib0235 article-title: Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains publication-title: Vaccine – volume: 16 start-page: 356 year: 2010 end-page: 359 ident: bib0165 article-title: Vaccine-associated paralytic poliomyelitis in an infant with perianal abscesses publication-title: J Infect Chemother. – volume: 27 start-page: 1057 year: 1983 end-page: 1065 ident: bib0085 article-title: Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin publication-title: Microbiol Immunol – volume: 59 start-page: 587 year: 2005 end-page: 635 ident: bib0115 article-title: Vaccine-derived polioviruses and the endgame strategy for global polio eradication publication-title: Annu Rev Microbiol – year: 2013 ident: bib0395 article-title: Labour and Welfare publication-title: Immunogenicity and safety of OPV, IPV, and DPT-IPV in terms of interchangeably – volume: 10 start-page: 635 year: 2011 end-page: 644 ident: bib0490 article-title: Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains publication-title: Expert Rev Vaccines – start-page: 598 year: 2013 end-page: 645 ident: bib0060 article-title: Poliovirus vaccine-live publication-title: Vaccines – volume: 31 start-page: 327 year: 1987 end-page: 336 ident: bib0080 article-title: Antigenic and biochemical characterization of poliovirus type 1 isolates publication-title: Microbiol Immunol – year: 2013 ident: bib0505 article-title: WHO technical working group meeting on revision of the WHO recommen-dations for the production and control of inactivated poliomyelitis vaccines: TRS no. 910, Annex 1 – year: 2012 ident: bib0335 article-title: Labour and welfare publication-title: A survey of vaccination coverage by routine OPV immunization in the spring of 2012 – start-page: 7 year: 2011 ident: bib0220 article-title: Labour and Welfare publication-title: A conference material—the fist conference on smooth promotion for IPV introduction – volume: 25 start-page: 7041 year: 2007 end-page: 7046 ident: bib0225 article-title: Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains publication-title: Vaccine – volume: 379 start-page: 520 year: 2012 ident: bib0350 article-title: Vaccine-associated paralytic poliomyelitis in Japan publication-title: Lancet – year: 2013 ident: bib0010 article-title: Polio Eradication and Endgame Strategic Plan 2013–2018 – start-page: 16 year: 2011 ident: bib0180 article-title: Labour and Welfare publication-title: A conference material—The fist conference on smooth promotion for IPV introduction – volume: 32 start-page: 4938 year: 2014 end-page: 4944 ident: bib0405 article-title: Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants publication-title: Vaccine – volume: 292 start-page: 1696 year: 2004 end-page: 1701 ident: bib0325 article-title: Vaccine policy changes and epidemiology of poliomyelitis in the United States publication-title: JAMA – volume: 7 start-page: 760 year: 1988 end-page: 765 ident: bib0400 article-title: Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey publication-title: Pediatr Infect Dis J – volume: 27 start-page: 248 year: 1999 end-page: 261 ident: bib0200 article-title: Development and clinical evaluation on the enhanced-potency inactivated poliovirus vaccine made from the Sabin strains publication-title: Clin Virol – year: 2012 ident: bib0305 article-title: Review report—tetrabik subcutaneous injection syringe – volume: 49 start-page: 129 year: 1973 end-page: 137 ident: bib0050 article-title: Poliomyelitis in Japan during the period 1962–68 after the introduction of mass vaccination with Sabin vaccine publication-title: Bull World Health Organ – volume: 61 start-page: 100 year: 2008 end-page: 103 ident: bib0175 article-title: Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000 publication-title: Jpn J Infect Dis – volume: 29 start-page: 3390 year: 2011 end-page: 3397 ident: bib0265 article-title: Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines publication-title: Vaccine – start-page: 18 year: 2014 ident: bib0375 article-title: Labour and welfare publication-title: Status of polio immunization and prevalence of antibodies against polioviruses—from a NESVPV survey in 2013 – start-page: 1 year: 2012 end-page: 12 ident: bib0120 article-title: Country progress report on maintaining polio-free status for the 18th regional commission for the certification of poliomyelitis eradication in the Western Pacific – volume: 66 start-page: 5087 year: 2000 end-page: 5091 ident: bib0430 article-title: Assessment of poliovirus eradication in Japan: genomic analysis of polioviruses isolated from river water and sewage in toyama prefecture publication-title: Appl Environ Microbiol – volume: 370 start-page: 829 year: 2014 end-page: 837 ident: bib0535 article-title: An inactivated enterovirus 71 vaccine in healthy children publication-title: N Engl J Med – volume: 14 start-page: 262 year: 2014 end-page: 263 ident: bib0515 article-title: Surveillance of hand, foot, and mouth disease for a vaccine publication-title: Lancet Infect Dis – volume: 45 start-page: 206 year: 1947 end-page: 218 ident: bib0045 article-title: Poliomyelitis in Japan publication-title: Am J Hyg – start-page: 1 year: 2013 end-page: 15 ident: bib0380 article-title: Country progress report on maintaining polio-free status for the 19th Regional Commission for the certification of poliomyelitis eradication in the Western Pacific – volume: 32 start-page: 1100 year: 2014 end-page: 1106 ident: bib0475 article-title: Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine publication-title: Vaccine – volume: 1 start-page: 589 year: 2012 end-page: 599 ident: bib0485 article-title: Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains publication-title: Pharm Patent Analyst – year: 2014 ident: bib0385 article-title: Squarekids subcutaneous injection syringe – year: 2012 ident: bib0015 article-title: Call for expressions of interest (EoI)—developing Sabin-inactivated polio vaccine (sIPV) – volume: 205 start-page: 237 year: 2012 end-page: 243 ident: bib0415 article-title: Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial publication-title: J Infect Dis – volume: 190 start-page: 1404 year: 2004 end-page: 1412 ident: bib0275 article-title: Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy publication-title: J Infect Dis – volume: 20 start-page: 63 year: 2001 end-page: 75 ident: bib0525 article-title: Immunologic correlates of protection induced by vaccination publication-title: Pediatr Infect Dis J – volume: 381 start-page: 1037 year: 2013 end-page: 1045 ident: bib0540 article-title: Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial publication-title: Lancet – year: 2011 ident: bib0390 article-title: Quadrivalent vaccine TAK-361S enters into phase II clinical trials in Japan – volume: 19 start-page: 20708 year: 2014 ident: bib0445 article-title: Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013 publication-title: Euro Surveill – volume: 208 start-page: 275 year: 2013 end-page: 283 ident: bib0290 article-title: Phase II and III clinical studies of Diphtheria–Tetanus–Acellular Pertussis vaccine containing inactivated polio vaccine derived from Sabin strains (DTaP-sIPV) publication-title: J Infect Dis – volume: 83 start-page: 1107 year: 2002 end-page: 1111 ident: bib0420 article-title: Prevalence of vaccine-derived polioviruses in the environment publication-title: J Gen Virol – volume: 194 start-page: 804 year: 2006 end-page: 807 ident: bib0270 article-title: Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine publication-title: J Infect Dis – reference: Sanofi Pasteur. [in Japanese] IMOVAX POLIO subcutaneous. 〈 – volume: 8 start-page: e1002599 year: 2012 ident: bib0470 article-title: Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge publication-title: PLoS Pathog – volume: 9 start-page: 169 year: 2011 end-page: 175 ident: bib0155 article-title: Japanese vaccinations and practices, with particular attention to polio and pertussis publication-title: Travel Med Infect Dis – volume: 356 start-page: 1461 year: 2000 end-page: 1463 ident: bib0425 article-title: Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan publication-title: Lancet – volume: 8 start-page: e83374 year: 2013 ident: bib0260 article-title: Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals publication-title: PLoS One – volume: 382 start-page: 1611 year: 2013 end-page: 1612 ident: bib0435 article-title: Polio lessons 2013: Israel, the West Bank, and Gaza publication-title: Lancet – volume: 32 start-page: 5399 year: 2014 end-page: 5404 ident: bib0480 article-title: Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: A phase I Trial in healthy adults in Cuba publication-title: Vaccine – volume: 33 start-page: 630 year: 2001 end-page: 631 ident: bib0150 article-title: Polio vaccine virus-associated meningoencephalitis in an infant with transient hypogammaglobulinemia publication-title: Scand J Infect Dis – volume: 21 start-page: 169 year: 1993 end-page: 177 ident: bib0245 article-title: Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains publication-title: Biologicals – volume: 381 start-page: 976 year: 2013 end-page: 977 ident: bib0520 article-title: Enterovirus 71 encephalitis: a new vaccine on the horizon? publication-title: Lancet – volume: 74 start-page: 685 year: 1993 end-page: 690 ident: bib0250 article-title: Antigenic structure of poliovirus in inactivated vaccines publication-title: J Gen Virol – volume: 41 start-page: 184 year: 2013 end-page: 189 ident: bib0285 article-title: Antibody responses of Macaca fascicularis against a new inactivated polio vaccine derived from Sabin strains (sIPV) in DTaP-sIPV vaccine publication-title: Biologicals – reference: . – volume: 48 start-page: 547 year: 1973 end-page: 554 ident: bib0065 article-title: Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin) publication-title: Bull World Health Organ – volume: 29 start-page: 7188 year: 2011 end-page: 7196 ident: bib0495 article-title: Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV publication-title: Vaccine – volume: 34 start-page: 151 year: 2006 end-page: 154 ident: bib0190 article-title: Development of inactivated poliovirus vaccine derived from Sabin strains publication-title: Biologicals – volume: 19 start-page: 277 year: 1966 end-page: 291 ident: bib0055 article-title: Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children publication-title: Jpn J Med Sci Biol – volume: 502 start-page: 601 year: 2013 end-page: 602 ident: bib0440 article-title: Polio risk looms over Europe publication-title: Nature – volume: 24 start-page: 178 year: 1978 end-page: 206 ident: bib0070 article-title: Parameters for differentiating vaccine-derived and wild poliovirus strains publication-title: Prog Med Virol – year: 2012 ident: bib0300 article-title: Review report—quattrovac subcutaneous injection syringe – volume: 32 start-page: 5163 year: 2014 end-page: 5169 ident: bib0280 article-title: A national reference for inactivated polio vaccine derived from Sabin strains in Japan publication-title: Vaccine – year: 2010 ident: bib0315 article-title: Fact sheet for poliovirus vaccine – volume: 31 start-page: 327 year: 1987 ident: 10.1016/j.vaccine.2014.11.015_bib0080 article-title: Antigenic and biochemical characterization of poliovirus type 1 isolates publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.1987.tb03093.x – volume: 29 start-page: 7188 year: 2011 ident: 10.1016/j.vaccine.2014.11.015_bib0495 article-title: Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV publication-title: Vaccine doi: 10.1016/j.vaccine.2011.05.079 – volume: 292 start-page: 1696 year: 2004 ident: 10.1016/j.vaccine.2014.11.015_bib0325 article-title: Vaccine policy changes and epidemiology of poliomyelitis in the United States publication-title: JAMA doi: 10.1001/jama.292.14.1696 – volume: 379 start-page: 520 year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0350 article-title: Vaccine-associated paralytic poliomyelitis in Japan publication-title: Lancet doi: 10.1016/S0140-6736(12)60232-3 – year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0010 – volume: 9 start-page: 169 year: 2011 ident: 10.1016/j.vaccine.2014.11.015_bib0155 article-title: Japanese vaccinations and practices, with particular attention to polio and pertussis publication-title: Travel Med Infect Dis doi: 10.1016/j.tmaid.2010.05.004 – volume: 345 start-page: 922 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0460 article-title: Polio eradication. Efficacy of inactivated poliovirus vaccine in India publication-title: Science doi: 10.1126/science.1255006 – volume: 78 start-page: 1479 year: 2000 ident: 10.1016/j.vaccine.2014.11.015_bib0140 article-title: A second WHO region declared polio-free publication-title: Bull World Health Organ – year: 2011 ident: 10.1016/j.vaccine.2014.11.015_bib0390 – start-page: 573 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0310 article-title: Poliovirus vaccine-inactivated – ident: 10.1016/j.vaccine.2014.11.015_bib0330 – volume: 55 start-page: 101 year: 2002 ident: 10.1016/j.vaccine.2014.11.015_bib0340 article-title: Development of vaccination policy in Japan: current issues and policy directions publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2002.101 – volume: 132 start-page: 11 year: 1979 ident: 10.1016/j.vaccine.2014.11.015_bib0100 article-title: Paralytic poliomyelitis in a child with agammaglobulinemia publication-title: Eur J Pediatr doi: 10.1007/BF00443199 – volume: 52 start-page: 146 year: 1999 ident: 10.1016/j.vaccine.2014.11.015_bib0510 article-title: Genetic analysis of wild polioviruses towards the eradication of poliomyelitis from the Western Pacific Region publication-title: Jpn J Infect Dis doi: 10.7883/yoken.52.146 – volume: 8 start-page: e1002599 year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0470 article-title: Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002599 – start-page: 1 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0380 – volume: 83 start-page: 1107 year: 2002 ident: 10.1016/j.vaccine.2014.11.015_bib0420 article-title: Prevalence of vaccine-derived polioviruses in the environment publication-title: J Gen Virol doi: 10.1099/0022-1317-83-5-1107 – year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0015 – volume: 52 start-page: 838 year: 2010 ident: 10.1016/j.vaccine.2014.11.015_bib0170 article-title: Vaccine-associated paralytic poliomyelitis in a non-immunocompromised infant publication-title: Pediatr Int doi: 10.1111/j.1442-200X.2010.03132.x – start-page: 18 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0375 article-title: Labour and welfare – volume: 63 start-page: 216 year: 2010 ident: 10.1016/j.vaccine.2014.11.015_bib0160 article-title: A case of paralytic poliomyelitis associated with poliovirus vaccine strains in hokkaido, Japan publication-title: Jpn J Infect Dis doi: 10.7883/yoken.63.216 – volume: 32 start-page: 4938 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0405 article-title: Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants publication-title: Vaccine doi: 10.1016/j.vaccine.2014.07.029 – volume: 84 start-page: 1781 year: 2003 ident: 10.1016/j.vaccine.2014.11.015_bib0230 article-title: Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains publication-title: J Gen Virol doi: 10.1099/vir.0.19088-0 – volume: 370 start-page: 818 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0530 article-title: Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China publication-title: N Engl J Med doi: 10.1056/NEJMoa1304923 – volume: 16 start-page: 135 year: 1963 ident: 10.1016/j.vaccine.2014.11.015_bib0075 article-title: Studies on the antigenic serodifferentiation of poliovirus strains publication-title: Jpn J Med Sci Biol – volume: 8 start-page: e83374 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0260 article-title: Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals publication-title: PLoS One doi: 10.1371/journal.pone.0083374 – volume: 25 start-page: 575 year: 1981 ident: 10.1016/j.vaccine.2014.11.015_bib0090 article-title: Structural proteins of poliovirus type 2 isolates publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.1981.tb00059.x – volume: 190 start-page: 1404 year: 2004 ident: 10.1016/j.vaccine.2014.11.015_bib0275 article-title: Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy publication-title: J Infect Dis doi: 10.1086/424524 – volume: 143 start-page: 609 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0370 article-title: Cummulative vaccination covrrage of oral poliovirus vaccine and inactivated poliovirus vaccine obtained by the nationwide survey in 2013 publication-title: J Jpn Med Assoc – volume: 10 start-page: 635 year: 2011 ident: 10.1016/j.vaccine.2014.11.015_bib0490 article-title: Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains publication-title: Expert Rev Vaccines doi: 10.1586/erv.11.51 – volume: 32 start-page: 5163 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0280 article-title: A national reference for inactivated polio vaccine derived from Sabin strains in Japan publication-title: Vaccine doi: 10.1016/j.vaccine.2014.07.065 – year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0395 article-title: Labour and Welfare – volume: 19 start-page: 20708 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0445 article-title: Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013 publication-title: Euro Surveill doi: 10.2807/1560-7917.ES2014.19.7.20708 – volume: 26 start-page: 45 year: 2011 ident: 10.1016/j.vaccine.2014.11.015_bib0185 article-title: Developmemnt of Sabin strain-derived inactivated poliovirus vaccine in Japan publication-title: BIO Clinica – volume: 366 start-page: 394 year: 2005 ident: 10.1016/j.vaccine.2014.11.015_bib0455 article-title: Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand publication-title: Lancet doi: 10.1016/S0140-6736(05)66386-6 – volume: 30 start-page: 4752 year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0345 article-title: Current issues with the immunization program in Japan: can we fill the “vaccine gap”? publication-title: Vaccine doi: 10.1016/j.vaccine.2012.04.026 – volume: 141 start-page: 1052 year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0365 article-title: A survey of the number of immunization with inctibvated poliovius vaccine; The survey results in 2011 publication-title: J Jpn Med Assoc – volume: 27 start-page: 248 year: 1999 ident: 10.1016/j.vaccine.2014.11.015_bib0200 article-title: Development and clinical evaluation on the enhanced-potency inactivated poliovirus vaccine made from the Sabin strains publication-title: Clin Virol – volume: 370 start-page: 829 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0535 article-title: An inactivated enterovirus 71 vaccine in healthy children publication-title: N Engl J Med doi: 10.1056/NEJMoa1303224 – volume: 205 start-page: 237 year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0415 article-title: Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial publication-title: J Infect Dis doi: 10.1093/infdis/jir723 – volume: 194 start-page: 804 year: 2006 ident: 10.1016/j.vaccine.2014.11.015_bib0270 article-title: Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine publication-title: J Infect Dis doi: 10.1086/506949 – volume: 31 start-page: 5531 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0410 article-title: Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults publication-title: Vaccine doi: 10.1016/j.vaccine.2013.09.021 – volume: 74 start-page: 685 issue: Pt 4 year: 1993 ident: 10.1016/j.vaccine.2014.11.015_bib0250 article-title: Antigenic structure of poliovirus in inactivated vaccines publication-title: J Gen Virol doi: 10.1099/0022-1317-74-4-685 – volume: 172 start-page: 1213 year: 2010 ident: 10.1016/j.vaccine.2014.11.015_bib0035 article-title: From emergence to eradication: the epidemiology of poliomyelitis deconstructed publication-title: Am J Epidemiol doi: 10.1093/aje/kwq320 – volume: 26 start-page: 4978 year: 2008 ident: 10.1016/j.vaccine.2014.11.015_bib0320 article-title: World wide experience with inactivated poliovirus vaccine publication-title: Vaccine doi: 10.1016/j.vaccine.2008.07.026 – year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0335 article-title: Labour and welfare – volume: 381 start-page: 976 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0520 article-title: Enterovirus 71 encephalitis: a new vaccine on the horizon? publication-title: Lancet doi: 10.1016/S0140-6736(13)60286-X – volume: 125 start-page: 759 year: 1910 ident: 10.1016/j.vaccine.2014.11.015_bib0030 article-title: On the Hein Mwdin's disease publication-title: Jikazasshi – volume: 25 start-page: 905 year: 1981 ident: 10.1016/j.vaccine.2014.11.015_bib0110 article-title: Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.1981.tb00095.x – volume: 23 start-page: 177 year: 2000 ident: 10.1016/j.vaccine.2014.11.015_bib0145 article-title: Acute disseminated encephalomyelitis associated with poliomyelitis vaccine publication-title: Pediatr Neurol doi: 10.1016/S0887-8994(00)00167-3 – volume: 66 start-page: 5087 year: 2000 ident: 10.1016/j.vaccine.2014.11.015_bib0430 article-title: Assessment of poliovirus eradication in Japan: genomic analysis of polioviruses isolated from river water and sewage in toyama prefecture publication-title: Appl Environ Microbiol doi: 10.1128/AEM.66.11.5087-5091.2000 – volume: 32 start-page: 1100 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0475 article-title: Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine publication-title: Vaccine doi: 10.1016/j.vaccine.2013.12.025 – volume: 17 start-page: 2059 year: 1999 ident: 10.1016/j.vaccine.2014.11.015_bib0235 article-title: Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains publication-title: Vaccine doi: 10.1016/S0264-410X(98)00409-5 – volume: 41 start-page: 184 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0285 article-title: Antibody responses of Macaca fascicularis against a new inactivated polio vaccine derived from Sabin strains (sIPV) in DTaP-sIPV vaccine publication-title: Biologicals doi: 10.1016/j.biologicals.2012.12.004 – volume: 20 start-page: 63 year: 2001 ident: 10.1016/j.vaccine.2014.11.015_bib0525 article-title: Immunologic correlates of protection induced by vaccination publication-title: Pediatr Infect Dis J doi: 10.1097/00006454-200101000-00013 – start-page: 1 year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0120 – volume: 48 start-page: 61 year: 1995 ident: 10.1016/j.vaccine.2014.11.015_bib0095 article-title: Characterization of a wild poliovirus type 3 isolated Japan in 1993 publication-title: Jpn J Med Sci Biol doi: 10.7883/yoken1952.48.61 – year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0355 article-title: Labour and Welfare – volume: 45 start-page: 206 year: 1947 ident: 10.1016/j.vaccine.2014.11.015_bib0045 article-title: Poliomyelitis in Japan publication-title: Am J Hyg – volume: 25 start-page: 299 year: 1997 ident: 10.1016/j.vaccine.2014.11.015_bib0240 article-title: Potency of wild-type or sabin trivalent inactivated poliovirus vaccine, by enzyme-linked immunosorbent assay using monoclonal antibiotics specific for each antigenic site publication-title: Biologicals doi: 10.1006/biol.1997.0100 – volume: 19 start-page: 277 year: 1966 ident: 10.1016/j.vaccine.2014.11.015_bib0055 article-title: Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children publication-title: Jpn J Med Sci Biol doi: 10.7883/yoken1952.19.277 – volume: 21 start-page: 169 year: 1993 ident: 10.1016/j.vaccine.2014.11.015_bib0245 article-title: Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains publication-title: Biologicals doi: 10.1006/biol.1993.1070 – volume: 27 start-page: 1057 year: 1983 ident: 10.1016/j.vaccine.2014.11.015_bib0085 article-title: Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.1983.tb02939.x – year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0130 article-title: Maintaining polio-free certification in the World Health Organization Western Pacific Region for over a decade publication-title: J Infect Dis doi: 10.1093/infdis/jiu164 – volume: 19 start-page: 1456 year: 2001 ident: 10.1016/j.vaccine.2014.11.015_bib0215 article-title: Analysis of the accumulation of mutants in Sabin attenuated polio vaccine viruses passaged in Vero cells publication-title: Vaccine doi: 10.1016/S0264-410X(00)00350-9 – year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0385 – volume: 32 start-page: 4259 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0135 article-title: Are we there yet? Assessing achievement of vaccine-preventable disease goals in WHO's Western Pacific Region publication-title: Vaccine doi: 10.1016/j.vaccine.2014.02.093 – volume: 28 start-page: 72 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0295 article-title: Efficacy and safety of absorbed acellular pertussis–diphtheria–tetanus–Sabin strains derivd inactivated poliovirus combination vaccine publication-title: BIO Clin – volume: 49 start-page: 129 year: 1973 ident: 10.1016/j.vaccine.2014.11.015_bib0050 article-title: Poliomyelitis in Japan during the period 1962–68 after the introduction of mass vaccination with Sabin vaccine publication-title: Bull World Health Organ – year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0300 – year: 2004 ident: 10.1016/j.vaccine.2014.11.015_bib0210 – year: 2010 ident: 10.1016/j.vaccine.2014.11.015_bib0315 – volume: 105 start-page: 163 year: 2001 ident: 10.1016/j.vaccine.2014.11.015_bib0195 article-title: Progress with inactivated poliovirus vaccines derived from the Sabin strains publication-title: DevBiol – start-page: 7 year: 2011 ident: 10.1016/j.vaccine.2014.11.015_bib0220 article-title: Labour and Welfare – volume: 31 start-page: 1298 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0255 article-title: Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains publication-title: Vaccine doi: 10.1016/j.vaccine.2012.12.076 – volume: 48 start-page: 547 year: 1973 ident: 10.1016/j.vaccine.2014.11.015_bib0065 article-title: Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin) publication-title: Bull World Health Organ – volume: 14 start-page: 262 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0515 article-title: Surveillance of hand, foot, and mouth disease for a vaccine publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(13)70330-X – volume: 34 start-page: 151 year: 2006 ident: 10.1016/j.vaccine.2014.11.015_bib0190 article-title: Development of inactivated poliovirus vaccine derived from Sabin strains publication-title: Biologicals doi: 10.1016/j.biologicals.2006.02.010 – volume: 195 start-page: 148 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0450 article-title: Development of real-time PCR to detect oral vaccine-like poliovirus and its application to environmental surveillance publication-title: J Virol Methods doi: 10.1016/j.jviromet.2013.10.004 – volume: 37 start-page: 46 year: 1982 ident: 10.1016/j.vaccine.2014.11.015_bib0105 article-title: Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients publication-title: Infect Immun doi: 10.1128/IAI.37.1.46-53.1982 – year: 2009 ident: 10.1016/j.vaccine.2014.11.015_bib0020 – volume: 16 start-page: 356 year: 2010 ident: 10.1016/j.vaccine.2014.11.015_bib0165 article-title: Vaccine-associated paralytic poliomyelitis in an infant with perianal abscesses publication-title: J Infect Chemother. doi: 10.1007/s10156-010-0065-5 – volume: 3 start-page: 1 year: 1960 ident: 10.1016/j.vaccine.2014.11.015_bib0040 article-title: Poliomyelitis in Japan publication-title: Annu Rep Inst Virus Res, Kyoto Univ – volume: 502 start-page: 601 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0440 article-title: Polio risk looms over Europe publication-title: Nature doi: 10.1038/502601a – start-page: 16 year: 2011 ident: 10.1016/j.vaccine.2014.11.015_bib0180 article-title: Labour and Welfare – volume: 34 start-page: 155 year: 2006 ident: 10.1016/j.vaccine.2014.11.015_bib0500 article-title: Technology transfer of Sabin-IPV to new developing country markets publication-title: Biologicals doi: 10.1016/j.biologicals.2006.02.011 – volume: 34 start-page: 127 year: 2006 ident: 10.1016/j.vaccine.2014.11.015_bib0025 article-title: Post-eradication poliovirus facility-associated community risks publication-title: Biologicals doi: 10.1016/j.biologicals.2006.03.003 – volume: 36 start-page: 125 year: 1986 ident: 10.1016/j.vaccine.2014.11.015_bib0205 article-title: Preparation of inactivated poliomyelitis vaccine with attenuated Sabin strains publication-title: Uirusu doi: 10.2222/jsv.36.125 – volume: 24 start-page: 178 year: 1978 ident: 10.1016/j.vaccine.2014.11.015_bib0070 article-title: Parameters for differentiating vaccine-derived and wild poliovirus strains publication-title: Prog Med Virol – year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0305 – year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0505 – volume: 61 start-page: 100 year: 2008 ident: 10.1016/j.vaccine.2014.11.015_bib0175 article-title: Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000 publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2008.100 – volume: 381 start-page: 1037 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0540 article-title: Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial publication-title: Lancet doi: 10.1016/S0140-6736(12)61764-4 – start-page: 598 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0060 article-title: Poliovirus vaccine-live – volume: 59 start-page: 587 year: 2005 ident: 10.1016/j.vaccine.2014.11.015_bib0115 article-title: Vaccine-derived polioviruses and the endgame strategy for global polio eradication publication-title: Annu Rev Microbiol doi: 10.1146/annurev.micro.58.030603.123625 – volume: 29 start-page: 3390 year: 2011 ident: 10.1016/j.vaccine.2014.11.015_bib0265 article-title: Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines publication-title: Vaccine doi: 10.1016/j.vaccine.2011.02.085 – volume: 356 start-page: 1461 year: 2000 ident: 10.1016/j.vaccine.2014.11.015_bib0425 article-title: Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan publication-title: Lancet doi: 10.1016/S0140-6736(00)02868-3 – volume: 382 start-page: 1611 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0435 article-title: Polio lessons 2013: Israel, the West Bank, and Gaza publication-title: Lancet doi: 10.1016/S0140-6736(13)62331-4 – volume: 208 start-page: 275 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0290 article-title: Phase II and III clinical studies of Diphtheria–Tetanus–Acellular Pertussis vaccine containing inactivated polio vaccine derived from Sabin strains (DTaP-sIPV) publication-title: J Infect Dis doi: 10.1093/infdis/jit155 – volume: 178 start-page: 1579 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0465 article-title: The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting publication-title: Am J Epidemiol doi: 10.1093/aje/kwt203 – volume: 33 start-page: 630 year: 2001 ident: 10.1016/j.vaccine.2014.11.015_bib0150 article-title: Polio vaccine virus-associated meningoencephalitis in an infant with transient hypogammaglobulinemia publication-title: Scand J Infect Dis doi: 10.1080/00365540110027204 – volume: 7 start-page: 760 year: 1988 ident: 10.1016/j.vaccine.2014.11.015_bib0400 article-title: Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey publication-title: Pediatr Infect Dis J doi: 10.1097/00006454-198811000-00003 – volume: 32 start-page: 5399 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0480 article-title: Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: A phase I Trial in healthy adults in Cuba publication-title: Vaccine doi: 10.1016/j.vaccine.2014.07.109 – volume: 117 start-page: 766 year: 2013 ident: 10.1016/j.vaccine.2014.11.015_bib0360 article-title: Imported inactibated polio vaccine use in Kobe city Nihon Shonika Gakkai Zasshi publication-title: J Jpn Pediatr Soc – volume: 25 start-page: 7041 year: 2007 ident: 10.1016/j.vaccine.2014.11.015_bib0225 article-title: Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains publication-title: Vaccine doi: 10.1016/j.vaccine.2007.07.060 – volume: 1 start-page: 589 year: 2012 ident: 10.1016/j.vaccine.2014.11.015_bib0485 article-title: Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains publication-title: Pharm Patent Analyst doi: 10.4155/ppa.12.70 – volume: 32 start-page: 4117 year: 2014 ident: 10.1016/j.vaccine.2014.11.015_bib0005 article-title: Polio vaccines: WHO position paper, January 2014—recommendations publication-title: Vaccine doi: 10.1016/j.vaccine.2014.04.023 – volume: 28 start-page: 80 year: 2005 ident: 10.1016/j.vaccine.2014.11.015_bib0125 article-title: Isolation of vaccine-derived strain in epodemiological surveillnace of poliovirus |
| SSID | ssj0005319 |
| Score | 2.3792872 |
| SecondaryResourceType | review_article |
| Snippet | During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk of... Abstract During the endgame of global polio eradication, the universal introduction of inactivated poliovirus vaccines is urgently required to reduce the risk... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1975 |
| SubjectTerms | Allergy and Immunology Disease Outbreaks - prevention & control Enterovirus C Epidemics Global polio eradication History, 20th Century History, 21st Century Humans Immunization Immunization Programs Inactivated poliovirus vaccine Japan Japan - epidemiology Manufacturing Oral poliovirus vaccine Poliomyelitis Poliomyelitis - epidemiology Poliomyelitis - prevention & control Poliovirus Poliovirus vaccine Poliovirus Vaccine, Inactivated - history Poliovirus Vaccine, Inactivated - therapeutic use Poliovirus Vaccine, Oral - therapeutic use Randomized Controlled Trials as Topic Risk reduction Sabin strain Vaccination - statistics & numerical data Vaccine-associated paralytic poliomyelitis Vaccine-derived poliovirus Vaccines |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9UwFA86UfYiev2qTokge1rvmt40yX0SEccYTAbbpG8hzQdsSDvXey_sv985bdr6MDcfS3LapCc555ecL0K-WOWFVTKkYYm3VUXhUxOqImU8AL73AkAGxjsf_xSH5_yoLMp44dZGt8pBJnaC2jUW78j3mZRYmwSk6derPylWjULraiyh8Zg8YQBVcFXLUk4uHouusAccM3jKWVZOETz7l_ONsWi6Ru8uPsdEnlgZ927d9C_s2emggxfkeQSP9FvP7Zfkka9n5GlfTvJmRp4dR0P5jOye9Cmpb_bo2RRh1e7RXXoyJasGmtkv9IfpgnLpQP6K2L98iaipHb1Ah3bXZ5qlTYBnDIjYAFB1FOs8NJuL63VL42xb6uCdG2jD6BV6auD4TduuGkULpPQINHT9mpwf_Dj7fpjGcgypFZKt0ioYzlzwPrNc2EJlC5d767xbWqWK4G3OnAoGMIwXiLoqB1CMW0B0PFTcyMUbslU3tX9HqMD4V6ZMJT0gxpArFoQBMFGJkIOUMQnhAyO0jbnKcZC_9eCUdqnjjDTyD84xGviXkPlIdtUn63iIQAxc1kMkKshODerkIUJ5F6FvowRoNdNtrjN9mnWIMyvxIAtzzRKiRsoIcnrw8j8f3RkWop6-M-6LhHwem0FGoOHH1L5Zd31Ar6EB-p4-AEQB6kPPhLztF_n4DzGNncqW2fv7B_CBbMNoRefXJHfI1up67T8CZFtVn7p9eQsMyUBl priority: 102 providerName: ProQuest |
| Title | Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X14015400 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X14015400 https://dx.doi.org/10.1016/j.vaccine.2014.11.015 https://www.ncbi.nlm.nih.gov/pubmed/25448090 https://www.proquest.com/docview/1776184284 https://www.proquest.com/docview/1775381559 https://www.proquest.com/docview/1846310775 |
| Volume | 34 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: ACRLP dateStart: 20091030 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: AIKHN dateStart: 20091030 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection 2013 customDbUrl: eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1873-2518 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: AKRWK dateStart: 19831201 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1873-2518 dateEnd: 20250730 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: 7X7 dateStart: 20020101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1873-2518 dateEnd: 20250730 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: BENPR dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1873-2518 dateEnd: 20250730 omitProxy: true ssIdentifier: ssj0005319 issn: 0264-410X databaseCode: 8C1 dateStart: 20020101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB5VRSAuCMLLUNAioZ7qxE7s3c2xRK1CUaOItii31XofUirkVHUSqRd-OzP2OimiUMTFie2ZeO2ZzHzrnQfARyMdN1L42A_pbVWeu1j7Io_TzCO-dxxBBuU7n074-CI7meWzHRi1uTAUVhlsf2PTa2sdjvTC0-xdzee9s6T25cmMpgiIO2jeTtW_UKe7P26FeQzq5h5EHBP1Nound9lda0PL1xThlXWpmCd1x73bP_0Jf9Z-6PgpPAkAkh02Y3wGO67swMOmpeRNBx6dhsXyDuxPm7LUNwfsfJtlVR2wfTbdFqxGns43iompE3NZy_4czK14IqZLy-YU1G6barNs4XGfkiLWCFYto14Pi_X8elWxcLcVs_ibazxHGSzsTOMUnFV1R4oKWdkJeunyBVwcH52PxnFoyRAbLtJlXHidpdY7l5iMm1wmA9t3xjo7NFLm3pl-aqXXiGMcJ-RVWIRjmUFUl_ki02LwEnbLReleA-OUA5tKXQiH0vN9mXquEVAU3PfR0ugIslYQyoR65TTI76oNTLtU4Y4UyQ_nMgrlF0F3w3bVFOy4j4G3UlZtNiraT4Uu5T5GcRejq4IVqFSqqr5K1G-aGoHccP6i7P9y0b1WEdX2OkJQ3x5EGhF82JxGO0GLP7p0i1VNg76NFqH_QoNgFOE-UkbwqlHyzTOkUnYyGSZv_n_sb-Ex7vE67knswe7yeuXeIaRbFu_r_yxuxUzgVo7w-4PDz1_GE_z8dDSZfv0J3DVPSg |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIh4XBOEVKLBI0FOd2s567RwQQkCVPlJVaop8W9b7kFohu9RJUP4Uv5EZP2IOpeXSo-Ude9eznvlm5wXwTidW6CR2nhvRaVUUWU-5LPIC7hDfW4Egg_KdJ4difML30ihdg99tLgyFVbYysRLUptB0Rr4dxDH1JkFp-vH8p0ddo8i72rbQqLfFvl3-QpOt_LD7Bfn7Pgx3vk4_j72mq4CnRRzMvMwpHhhnra-50FHiD01otbFmpJMkclaHgUmcQlVsBYGHzCCi4BqBCXcZV_EQn3sLbvOhz6lWf5zGXUjJsGokgmYN93jgp13G0PbZYKE0ucopmowPqHAodeK9XBf-C-tWOm_nITxowCr7VO-uR7Bm8x7cqdtXLntwd9I45nuweVSXwF5usWmX0VVusU121BXHRpreN4q_qZKAWUv-GPRfsUtM5YadUgC9qSvbssLhNSVgLBAYG0Z9JYrF6cW8ZM1qS2bwmQu8R9ky7Fihuc_KqvtFiaRsDxFB_gROboRRT2E9L3L7HJigfNsgUVlsEaG6MAmcUAheMuFClGqqD7xlhNRNbXSa5A_ZBsGdyWZFkviHdpNE_vVhsCI7r4uDXEcgWi7LNvMVZbVE9XUdYXwZoS0biVPKQJah9OWxXyFcPyXDGdfq9yFZUTagqgZL__PSjXYjyu49q_-wD29Xt1EmkaNJ5baYV2NQj5LD-4oxCHzRtMCRfXhWb_LVN6SyeYk_8l9cPYE3cG88nRzIg93D_ZdwH2cuqpiqeAPWZxdz-wrh4ix7Xf2jDL7ftFD4A8hZfvE |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIiouCMLLUGCRoKc6sZ31rnNACFGiPmgVqS3KbVnvQ2qFnFInQflr_Dpm_Eg4lJZLj5F37N3MevYbzzczAO9M5oTJpA_9gL5WpakLtc_TMOYe8b0TCDIo3_nwSOye8v1xOl6D320uDNEqW5tYGWo7MfSNvBdLSb1J0Jr2fEOLGO0MP178DKmDFEVa23Ya9RY5cItf6L6VH_Z2UNfvk2T45eTzbth0GAiNkPE0zL3msfXORYYLk2ZR3ybOWGcHJstS70wS28xrPJadICCRW0QX3CBI4T7nWvbxvnfgruzzPtHJ5Fiu6CX9qqkIujg85HE0XmUP9c67c20obE7MMt6lIqLUlffqc_FfuLc6_4YP4UEDXNmneqc9gjVXdOBe3cpy0YGNwyZI34GtUV0Oe7HNTlbZXeU222KjVaFslOl8Iy5OlRDMWvHHYP7iMTFdWHZGZHpbV7llE4-_KRljjiDZMuoxMZmfXc5K1qy2ZBbvOcdrlDnDjjW6_qysOmGUKMr2ER0UT-D0VhT1FNaLSeGeAxOUextnOpcO0apPstgLjUAmFz5BC6cD4K0ilGnqpNMkf6iWEHeumhUp0h_6UAr1F0B3KXZRFwq5SUC0WlZtFizabYVH2U2C8ipBVzbWp1SxKhMVqeOoQrvRmJxoXGsUQLaUbABWDZz-56Gb7UZUq-cs38kA3i4vo32ioJMu3GRWjcEzlYLf14xBEIxuBo4M4Fm9yZf_IZXQy6JB9OL6CbyBDTQH6uve0cFLuI8TFxW9Sm7C-vRy5l4hcpzmr6tXlMH327YJfwC3uYMs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+introduction+of+inactivated+poliovirus+vaccines+derived+from+Sabin+strains+in+Japan&rft.jtitle=Vaccine&rft.au=Shimizu%2C+Hiroyuki&rft.date=2016-04-07&rft.issn=0264-410X&rft.volume=34&rft.issue=16&rft.spage=1975&rft.epage=1985&rft_id=info:doi/10.1016%2Fj.vaccine.2014.11.015&rft.externalDBID=ECK1-s2.0-S0264410X14015400&rft.externalDocID=1_s2_0_S0264410X14015400 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X16X00163%2Fcov150h.gif |